LYC Healthcare Berhad (KLSE:LYC)
Malaysia · Delayed Price · Currency is MYR 0.0150
+0.0050 (50.00%)
At close: Sep 21, 2026
LYC Healthcare Berhad Income Statement
Financials in millions MYR. Fiscal year is April - March.
Millions MYR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 137.05 | 135.08 | 155.52 | 128.99 | 92.28 | 64.6 | |
Revenue Growth | -7.53% | -13.15% | 20.57% | 39.78% | 42.86% | 144.56% |
Cost of Revenue | 87.57 | 82.14 | 86.55 | 60.72 | 50.7 | 32.41 |
Gross Profit | 49.49 | 52.93 | 68.97 | 68.27 | 41.58 | 32.19 |
Selling, General & Admin | 50.22 | 54.18 | 67.05 | 74.67 | 39.94 | 32.15 |
Other Operating Expenses | -0.54 | - | - | - | -0.15 | -7.63 |
Operating Expenses | 49.86 | 54.37 | 66.97 | 75.95 | 40.01 | 24.55 |
Operating Income | -0.38 | -1.44 | 2 | -7.68 | 1.57 | 7.64 |
Interest Expense | -9.31 | -10.23 | -10.71 | -9.47 | -11.22 | -8.76 |
Interest & Investment Income | 0.3 | 0.24 | 0.23 | 0.39 | 0.26 | 0.11 |
Earnings From Equity Investments | -0.04 | 0.03 | -0.19 | -1.4 | -2.23 | -0.51 |
Other Non Operating Income (Expenses) | 4.4 | 4.39 | 4.09 | 5.94 | -0.05 | -0.05 |
EBT Excluding Unusual Items | -5.03 | -7.01 | -4.57 | -12.22 | -11.67 | -1.58 |
Merger & Restructuring Charges | - | - | - | -0.07 | -0.19 | -0.29 |
Impairment of Goodwill | -1.5 | -1.5 | -1.87 | - | - | - |
Asset Writedown | -0.32 | -0.32 | -1.64 | -0.55 | - | - |
Other Unusual Items | - | - | - | - | - | 0.64 |
Pretax Income | -6.85 | -8.83 | -8.09 | -12.84 | -11.86 | -1.22 |
Income Tax Expense | 3.91 | 3.87 | 4.13 | 3.68 | 2.93 | 3.03 |
Earnings From Continuing Operations | -10.76 | -12.69 | -12.22 | -16.52 | -14.8 | -4.25 |
Net Income to Company | -10.76 | -12.69 | -12.22 | -16.52 | -14.8 | -4.25 |
Minority Interest in Earnings | -10.81 | -10.24 | -4.85 | -4.26 | -4.39 | -4.97 |
Net Income | -21.57 | -22.94 | -17.07 | -20.78 | -19.19 | -9.23 |
Net Income to Common | -21.57 | -22.94 | -17.07 | -20.78 | -19.19 | -9.23 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 740 | 740 | 715 | 715 | 550 | 436 |
Shares Outstanding (Diluted) | 740 | 740 | 715 | 715 | 550 | 436 |
Shares Change | 1.88% | 3.50% | - | 29.88% | 26.33% | 20.38% |
EPS (Basic) | -0.03 | -0.03 | -0.02 | -0.03 | -0.03 | -0.02 |
EPS (Diluted) | -0.03 | -0.03 | -0.02 | -0.03 | -0.03 | -0.02 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 17.72 | 26.47 | 22.74 | 5.03 | 2.46 | -2.54 |
Free Cash Flow Per Share | 0.02 | 0.04 | 0.03 | 0.01 | 0.00 | -0.01 |
Gross Margin | 36.11% | 39.19% | 44.35% | 52.92% | 45.06% | 49.83% |
Operating Margin | -0.27% | -1.06% | 1.28% | -5.96% | 1.70% | 11.83% |
Profit Margin | -15.74% | -16.98% | -10.97% | -16.11% | -20.79% | -14.28% |
Free Cash Flow Margin | 12.93% | 19.60% | 14.62% | 3.90% | 2.67% | -3.93% |
EBITDA | 7.31 | 6.32 | 10.13 | -0.09 | 4.84 | 10.4 |
EBITDA Margin | 5.33% | 4.68% | 6.51% | -0.07% | 5.24% | 16.10% |
D&A For EBITDA | 7.69 | 7.76 | 8.13 | 7.59 | 3.27 | 2.76 |
EBIT | -0.38 | -1.44 | 2 | -7.68 | 1.57 | 7.64 |
EBIT Margin | -0.27% | -1.06% | 1.28% | -5.96% | 1.70% | 11.83% |